We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




High-Risk Plaque Research Initiative To Identify Individuals at High Risk of Heart Attack or Stroke Two to Three Years before Occurrence

By MedImaging staff writers
Posted on 18 Feb 2008
A High-Risk Plaque Initiative (HRP Initiative) has been developed as a joint research effort to advance the understanding and management of high-risk plaque, which is believed to be the primary underlying cause of heart attacks and strokes. More...


As part of the research effort, NightHawk Radiology Holdings, Inc.'s (Coeur d'Alene, ID, USA) U.S. Board Certified radiologists will interpret chest computed tomography (CT) scans for approximately 6,000 study participants. Additionally, NightHawk Radiology Services expects its affiliated radiologists will read approximately 1,000 cardiac CT angiography (CTA) scans performed on a subset of participants believed to be at higher risk for a cardiac event. Cardiac CTA (CCTA) is a heart-imaging test that is quickly gaining acceptance for its ability to noninvasively determine whether fatty or calcium deposits (i.e., plaque) have built up in the coronary arteries. The purpose of the interpretation of the CT chest scans by NightHawk's affiliated radiologists is to identify clinically significant cardiac and noncardiac findings where the participant might benefit from its detection and follow-up.

Since there are currently no noninvasive methods of screening, diagnosis, or treatment for high-risk plaque, the HRP Initiative's goal is to provide a roadmap for the development of screening, diagnostic, and therapeutic interventions for high-risk plaque, and promote proper use to patients, providers, and payers.

NightHawk Radiology Services has deployed an independent imaging network system explicitly for the HRP Initiative and it expects to begin evaluating reads in the first quarter of 2008. "We are very excited to be a part of this initiative, which involves high-profile medical institutions, leading pharmaceutical and medical technology companies, and scientists in the fields of cardiology, pathology, and imaging,” said Dr. Paul Berger, chairman and chief executive officer of NightHawk Radiology Services. "Participating in this initiative builds on the opportunities that lie ahead for our new service offerings such as CCTA, which we believe will continue to gain acceptance as the standard noninvasive diagnostic tool.”

NightHawk Radiology provides services to radiology groups and hospitals throughout the United States.


Related Links:
NightHawk Radiology

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Autoclave
Advance
Gold Member
Electrode Solution and Skin Prep
Signaspray
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.